Your browser doesn't support javascript.
loading
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
Dillinger, Jean-Guillaume; Ducrocq, Gregory; Elbez, Yedid; Cohen, Marc; Bode, Christoph; Pollack, Charles; Nicolau, José C; Henry, Patrick; Kedev, Sasko; Wiviott, Stephen D; Sabatine, Marc S; Mehta, Shamir R; Steg, Philippe Gabriel.
Afiliación
  • Dillinger JG; From the Department of Cardiology, CREATIF, Hôpital Lariboisière, AP-HP, Université Paris Diderot-Sorbonne Paris Cité, Inserm U-942, France (J.-G.D., P.H.).
  • Ducrocq G; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, DHU FIRE, Hôpital Bichat, AP-HP, Université Paris Diderot-Sorbonne Paris Cité, Inserm U-1148, France (G.D., Y.E., P.G.S.).
  • Elbez Y; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, DHU FIRE, Hôpital Bichat, AP-HP, Université Paris Diderot-Sorbonne Paris Cité, Inserm U-1148, France (G.D., Y.E., P.G.S.).
  • Cohen M; Newark Beth Israel Medical Center, Rutgers-New Jersey Medical School, Newark (M.C.).
  • Bode C; Medizinische Universitatsklinik, Freiburg, Germany (C.B.).
  • Pollack C; Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA (C.P.).
  • Nicolau JC; Heart Institute (InCor), University of São Paulo Medical School, Brazil (J.C.N.).
  • Henry P; From the Department of Cardiology, CREATIF, Hôpital Lariboisière, AP-HP, Université Paris Diderot-Sorbonne Paris Cité, Inserm U-942, France (J.-G.D., P.H.).
  • Kedev S; University Clinic of Cardiology, Medical Faculty, University of St. Cyril and Methodius, Skopje, Macedonia (S.K.).
  • Wiviott SD; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.W., M.S.S.).
  • Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (S.D.W., M.S.S.).
  • Mehta SR; McMaster University and the Population Health Research Institute, Hamilton Health Sciences, ON, Canada (S.R.M.).
  • Steg PG; FACT (French Alliance for Cardiovascular Trials), an F-CRIN network, DHU FIRE, Hôpital Bichat, AP-HP, Université Paris Diderot-Sorbonne Paris Cité, Inserm U-1148, France (G.D., Y.E., P.G.S.) Gabriel.steg@aphp.fr.
Circ Cardiovasc Interv ; 11(6): e006084, 2018 06.
Article en En | MEDLINE | ID: mdl-29895599
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiempo de Coagulación de la Sangre Total / Coagulación Sanguínea / Inhibidores de Agregación Plaquetaria / Heparina / Monitoreo de Drogas / Complejo GPIIb-IIIa de Glicoproteína Plaquetaria / Síndrome Coronario Agudo / Intervención Coronaria Percutánea / Infarto del Miocardio sin Elevación del ST / Eptifibatida Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Cardiovasc Interv Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiempo de Coagulación de la Sangre Total / Coagulación Sanguínea / Inhibidores de Agregación Plaquetaria / Heparina / Monitoreo de Drogas / Complejo GPIIb-IIIa de Glicoproteína Plaquetaria / Síndrome Coronario Agudo / Intervención Coronaria Percutánea / Infarto del Miocardio sin Elevación del ST / Eptifibatida Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Cardiovasc Interv Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2018 Tipo del documento: Article